# Tamiflu

NDC: 0004-0822
Generic name: Oseltamivir Phosphate
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: POWDER, FOR SUSPENSION
Routes: ORAL
Marketing started: 20110321

FDA application: NDA021246

## Active ingredients

- OSELTAMIVIR PHOSPHATE: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0004-0822"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0004-0822
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee3c9555-60f2-4f82-a760-11983c86e97b